KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Equity (2016 - 2025)

Sarepta Therapeutics has reported Return on Equity over the past 15 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Equity for Q4 2025 was 0.0% at Sarepta Therapeutics, up from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q3 2024 and troughed at 0.02% in Q1 2023.
  • A 5-year average of 0.0% and a median of 0.0% in 2025 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -2bps in 2023 and later grew 2bps in 2024.
  • Year by year, Return on Equity stood at 0.0% in 2021, then plummeted by -1532bps to 0.01% in 2022, then skyrocketed by 72bps to 0.0% in 2023, then skyrocketed by 155bps to 0.0% in 2024, then tumbled by -137bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for SRPT at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.